Kohmann Bosshard Financial Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Hold
428
0.02% 215
2026
Q1
$210K Hold
428
0.02% 197
2025
Q4
$248K Hold
428
0.02% 248
2025
Q3
$208K Buy
+428
New +$199K 0.02% 216
2025
Q2
Sell
-428
Closed -$213K 207
2025
Q1
$213K Sell
428
-101
-19% -$54.7K 0.03% 205
2024
Q4
$275K Sell
529
-270
-34% -$148K 0.03% 163
2024
Q3
$494K Hold
799
0.06% 114
2024
Q2
$442K Hold
799
0.06% 115
2024
Q1
$464K Hold
799
0.06% 115
2023
Q4
$424K Hold
799
0.06% 116
2023
Q3
$404K Hold
799
0.07% 112
2023
Q2
$417K Hold
799
0.07% 109
2023
Q1
$461K Hold
799
0.09% 94
2022
Q4
$440K Buy
799
+40
+5% +$21.2K 0.09% 94
2022
Q3
$385K Hold
759
0.09% 89
2022
Q2
$412K Buy
759
+3
+0.4% +$1.65K 0.09% 88
2022
Q1
$447K Buy
+756
New +$434K 0.09% 85

Other funds holding TMO

Kohmann Bosshard Financial Services's TMO Position: Q2 2026 in Review

Kohmann Bosshard Financial Services held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 428 shares worth $215K. The position accounts for 0.02% of the portfolio, ranked #215.

Kohmann Bosshard Financial Services first reported a position in TMO in Q1 2022 and has held it in 17 quarters since. The position peaked at $494K in Q3 2024. 875 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Kohmann Bosshard Financial Services held 428 shares of Thermo Fisher Scientific worth $215K as of Q2 2026.
  • Kohmann Bosshard Financial Services left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.02% of Kohmann Bosshard Financial Services's portfolio in Q2 2026, its #215 holding.
  • Kohmann Bosshard Financial Services first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 17 quarters since.
  • Kohmann Bosshard Financial Services's Thermo Fisher Scientific position peaked at $494K in Q3 2024.
  • 875 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.